PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Chora, A.F.* ; Pedroso, D.* ; Kyriakou, E. ; Pejanovic, N.* ; Colaço, H.* ; Gozzelino, R.* ; Barros, A.* ; Willmann, K.* ; Velho, T.R.* ; Moita, C.* ; Santos, I.* ; Pereira, P.* ; Carvalho, S.* ; Martins, F.B.* ; Ferreira, J.A.* ; de Almeida, S.F.* ; Benes, V.* ; Anrather, J.* ; Weis, S.* ; Soares, M.P.* ; Geerlof, A. ; Neefjes, J.J.* ; Sattler, M.* ; Messias, A.C. ; Neves Costa, A.* ; Moita, L.F.*

DNA damage independent inhibition of NF-kB transcription by anthracyclines.

eLife 11:e77443 (2022)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Anthracyclines are among the most used and effective anticancer drugs. Their activity has been attributed to DNA double-strand breaks resulting from topoisomerase II poisoning and to eviction of histones from select sites in the genome. Here we show that the extensively used anthracyclines Doxorubicin, Daunorubicin and Epirubicin decrease the transcription of nuclear factor kappa B (NF-κB)-dependent gene targets, but not interferon responsive genes in primary mouse (Mus musculus) macrophages. Using an NMR-based structural approach, we demonstrate that anthracyclines disturb the complexes formed between the NF-kB subunit RelA and its DNA binding sites. The anthracycline variants Aclarubicin, Doxorubicinone and the newly developed Dimethyl-doxorubicin, which share anticancer properties with the other anthracyclines but do not induce DNA damage, also suppressed inflammation, thus uncoupling DNA damage from the effects on inflammation. These findings have implications for anticancer therapy and for the development of novel anti-inflammatory drugs with limited side effects for life-threatening conditions such as sepsis.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
8.713
0.000
2
1
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Immunology ; Inflammation ; Mouse; Induced Apoptosis; Rela Homodimer; Binding; Expression; Atm; Phosphorylation; Doxorubicin; Activation; Strand; Drugs
Sprache englisch
Veröffentlichungsjahr 2022
HGF-Berichtsjahr 2022
ISSN (print) / ISBN 2050-084X
e-ISSN 2050-084X
Zeitschrift eLife
Quellenangaben Band: 11, Heft: , Seiten: , Artikelnummer: e77443 Supplement: ,
Verlag eLife Sciences Publications
Verlagsort Sheraton House, Castle Park, Cambridge, Cb3 0ax, England
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Structural Biology (STB)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-503000-001
Förderungen European Research Council (ERC)
Fundacao para a Ciencia e a Tecnologia
H2020 European Research Council
DOI 10.7554/eLife.77443
WOS ID 000902224300001
WOS ID WOS:000902224300001
Scopus ID 85144597484
PubMed ID 36476511
Erfassungsdatum 2022-12-20
[➜Korrektur melden]